Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands

References

• Laupland KB, Gregson DB, Flemons WW, Hawkins D, Ross T, Church DL. Burden of community-onset bloodstream infection: a population-based assessment. Epidemiol Infect 2007;135:1037–42.
   PubMed Web of Science ®Google Scholar
• Stichting Werkgroep Antibiotica Beleid. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands (NethMap 2010). Available at: http://www.swab.nl (accessed 1 September 2010).
   Google Scholar
• Laupland KB, Gregson DB, Church DL, Ross T, Pitout JD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect 2008;14:1041–7.
   PubMed Web of Science ®Google Scholar
• Sader HS, Jones RN, Andrade-Baiocchi S, Biedenbach DJ. Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn Microbiol Infect Dis 2002;44:273–80.
   PubMed Web of Science ®Google Scholar
• Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998–2007. J Antimicrob Chemother 2009;64:169–74.
   PubMed Web of Science ®Google Scholar
• Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect 2007;55:254–9.
   PubMed Web of Science ®Google Scholar
• Lee CI, Lee NY, Yan JJ, Lee HC, Ko NY, Chang CM, Wu CJ, Chen PL, Wang LR, Ko WC. Extended-spectrum β-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia. J Microbiol Immunol Infect 2009;42:303–9.
   PubMedGoogle Scholar
• Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Muñoz A, Mensa J. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother 2009;63:568–74.
   PubMed Web of Science ®Google Scholar
• Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998–2007. J Antimicrob Chemother 2009;64:169–74.
   PubMed Web of Science ®Google Scholar
• Peña C, Gudiol C, Calatayud L, Tubau F, Dom nguez MA, Pujol M, Ariza J, Gudiol F. Infections due to Escherichia coli producing extended-spectrum β-lactamase among hospitalized patients: factors influencing mortality. J Hosp Infect 2008;68:116–22.
   PubMed Web of Science ®Google Scholar
• Sostarich AM, Zolldann D, Haefner H, Luetticken R, Schulze-Roebecke R, Lemmen SW. Impact of multiresistance of Gram-negative bacteria in bloodstream infection on mortality rates and length of stay. Infection 2008;36:31–5.
   PubMed Web of Science ®Google Scholar
• Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L, Chiusolo P, . Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 2009;58:299–307.
   PubMed Web of Science ®Google Scholar
• Kollef KE, Schramm GE, Wills AR, Reichley RM, Micek ST, Kollef MH. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant Gram-negative bacteria. Chest 2008;134:281–7.
   PubMed Web of Science ®Google Scholar
• Peralta G, Sánchez MB, Garrido JC, De Benito I, Cano ME, Martínez-Martínez L, . Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother 2007;60:855–63.
   PubMed Web of Science ®Google Scholar
• Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, . Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791–7.
   PubMed Web of Science ®Google Scholar
• Interpretations according to MIC breakpoints of the Dutch CRG. In: User's guide: Neo-Sensitabs TM susceptibility testing. 19th ed. Taastrup, Denmark: Rosco Diagnostica A/S; 2007/2008. pp. 32–6.
   Google Scholar
• Extended-spectrum beta-lactamases (ESBL). In: User's guide: Neo-Sensitabs TM susceptibility testing. 19th ed. Taastrup, Denmark: Rosco Diagnostica A/S; 2007/2008. pp. 126–8.
   Google Scholar
• Ball CS, Manson JM, Reid F, Tweedle DE. The pharmacokinetics of the biliary excretion of ciprofloxacin. HPB Surg 1989;1:319–26.
   PubMedGoogle Scholar
• Edmiston CE, Suarez EC, Walker AP, Demeure MP, Frantzides CT, Schulte WJ, . Penetration of ciprofloxacin and fleroxacin into biliary tract. Antimicrob Agents Chemother 1996;40:787–8.
   PubMed Web of Science ®Google Scholar
• Vigil KJ, Arachi JA, Aboufaycal H, Hachem RY, Reitzel RA, Jiang Y, . Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control 2009;37:741–5.
   PubMed Web of Science ®Google Scholar
• Chiang WC, Chen SY, Chien KL, Wu GH, Yen AM, Su CP, . Predictive model of antimicrobial-resistant Gram-negative bacteremia at the ED. Am J Emerg Med 2007;25:597–607.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Nichols T, Lamagni TL, Potz N, Reynolds R, Duckworth G. Ciprofloxacin-resistant Escherichia coli from bacteraemias in England; increasingly prevalent and mostly from men. J Antimicrob Chemother 2003;52:1040–2.
   PubMed Web of Science ®Google Scholar
• Thibaut S, Caillon J, Huart C, Grandjean G, Lombrail P, Potel G, . Susceptibility to the main antibiotics of Escherichia coli and Staphylococcus aureus strains identified in community acquired infections in France. Med Mal Infect 2010;40:74–80.
   PubMed Web of Science ®Google Scholar
• Durham LK, Ge M, Cuccia AJ, Quinn JP. Modeling antibiotic resistance to project future rates: quinolone resistance in Escherichia coli. Eur J Clin Microbiol Infect Dis 2010;29:353–6.
   PubMed Web of Science ®Google Scholar